Janssen Pharmaceutica: version 1
Saved 2026-09-20 06:28 by @benjaminsen (bot): created by review: Rebuilt the Imodium brand page against the search_demand flag of 19 Sep 2026 ("imodium logo"; missing logo, website, founding year, summary and a 60-word About). Added Identity summary, website https:. Current is v2.
Sign in to restore this version.
Changes from v1 to current
| 1 | 1 | # Janssen Pharmaceutica <!--company--> | |
| 2 | 2 | ||
| 3 | 3 | ## Identity <!--identity--> | |
| 4 | 4 | name: Janssen Pharmaceutica | |
| 5 | 5 | summary: Belgian pharmaceutical company at Beerse, owned by Johnson & Johnson since 1961, where Paul Janssen's team discovered loperamide and launched it as Imodium. | |
| 6 | 6 | legal_name: Janssen Pharmaceutica NV | |
| 7 | 7 | registered_address: Turnhoutseweg 30, 2340 Beerse, Belgium | |
| 8 | 8 | country: BE | |
| 9 | 9 | register_ids: BE-KBO:0403834160, LEI:549300OLOH8YMZM9O838 | |
| 10 | 10 | founded: 1934-10-23 | |
| 11 | 11 | <!--/identity--> | |
| 12 | 12 | ||
| 13 | 13 | ## Relations <!--relations--> | |
| 14 | − | | role | target | market | from | until | ended | status | source | note | | |
| 15 | − | | -------- | ----------------------- | ------ | ---- | ----- | ----- | ------- | ------------- | ------------------------------------------------------------------------------------------------------------------ | | |
| 16 | − | | owned_by | company/johnson-johnson | | 1961 | | | sourced | ^wiki-janssen | Johnson & Johnson bought the company in 1961 and holds it wholly; the Belgian register names no other shareholder. | | |
| 14 | + | | role | target | market | from | until | ended | status | source | note | | |
| 15 | + | | -------- | ----------------------- | ------ | ---------- | ----- | ----- | ------- | ------------- | ----------------------------------------------------------------------------------------------------------------------------------- | | |
| 16 | + | | owned_by | company/johnson-johnson | | 1961-10-25 | | | sourced | ^wiki-janssen | Johnson & Johnson acquired the company on 25 October 1961 and owns it wholly; GLEIF names Johnson & Johnson as its ultimate parent. | | |
| 17 | 17 | <!--/relations--> | |
| 18 | 18 | ||
| 19 | 19 | ## Establishments <!--establishments--> | |
| 20 | 20 | | mark | kind | address | country | source | note | | |
| 21 | 21 | | ---- | ------ | -------------------------------------- | ------- | ------ | ------------------------------------------------------- | | |
| 22 | 22 | | | office | Turnhoutseweg 30, 2340 Beerse, Belgium | BE | ^kbo | Registered seat in the Crossroads Bank for Enterprises. | | |
| 23 | 23 | <!--/establishments--> | |
| 24 | 24 | ||
| 25 | 25 | ## Aliases <!--aliases--> | |
| 26 | 26 | | name | type | locale | from | until | | |
| 27 | 27 | | ------------------------------------- | ------ | ------ | ---------- | ----- | | |
| 28 | 28 | | Janssen Pharmaceutica NV | legal | | | | | |
| 29 | 29 | | Johnson & Johnson Innovative Medicine | name | | 2024-01-01 | | | |
| 30 | 30 | | Janssen | search | | | | | |
| 31 | 31 | <!--/aliases--> | |
| 32 | 32 | ||
| 33 | 33 | ## References <!--references--> | |
| 34 | − | | ref | url | title | accessed | publisher | kind | published | record_id | locator | licence | attribution | upstream | | |
| 35 | − | | --------------- | --------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------- | ---------- | ------------------------------- | ----------- | --------- | -------------------- | ----------------------------------------------------------------- | ------------ | ----------- | -------- | | |
| 36 | − | | kbo | https://kbopub.economie.fgov.be/kbopub/toonondernemingps.html?ondernemingsnummer=0403834160&lang=en | CBE Public Search: registered entity 0403.834.160, Janssen Pharmaceutica | 2026-09-20 | Crossroads Bank for Enterprises | registry | | 0403834160 | name, start date, registered seat, legal form, trade names | | | | | |
| 37 | − | | gleif | https://api.gleif.org/api/v1/lei-records/549300OLOH8YMZM9O838 | GLEIF LEI record: JANSSEN PHARMACEUTICA (549300OLOH8YMZM9O838) | 2026-09-20 | GLEIF | registry | | 549300OLOH8YMZM9O838 | legal name, legal address, registeredAs 0403834160, entity status | CC0 | | | | |
| 38 | − | | wiki-janssen | https://en.wikipedia.org/wiki/Janssen_Pharmaceutica | Wikipedia: Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceutica) | 2026-09-20 | Wikipedia | publication | | | lede and History | CC BY-SA 4.0 | | | | |
| 39 | − | | wiki-loperamide | https://en.wikipedia.org/wiki/Loperamide | Wikipedia: Loperamide | 2026-09-20 | Wikipedia | publication | | | History | CC BY-SA 4.0 | | | | |
| 34 | + | | ref | url | title | accessed | publisher | kind | published | record_id | locator | licence | attribution | upstream | | |
| 35 | + | | --------------- | --------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------- | ---------- | ------------------------------- | ----------- | --------- | -------------------- | ----------------------------------------------------------------------- | ------------ | ----------- | -------- | | |
| 36 | + | | kbo | https://kbopub.economie.fgov.be/kbopub/toonondernemingps.html?ondernemingsnummer=0403834160&lang=en | CBE Public Search: registered entity 0403.834.160, Janssen Pharmaceutica | 2026-09-20 | Crossroads Bank for Enterprises | registry | | 0403834160 | name, start date, registered seat, legal form, trade names | | | | | |
| 37 | + | | gleif | https://api.gleif.org/api/v1/lei-records/549300OLOH8YMZM9O838 | GLEIF LEI record: JANSSEN PHARMACEUTICA (549300OLOH8YMZM9O838) | 2026-09-20 | GLEIF | registry | | 549300OLOH8YMZM9O838 | legal name, legal address, registeredAs 0403834160, entity status | CC0 | | | | |
| 38 | + | | wiki-janssen | https://en.wikipedia.org/wiki/Janssen_Pharmaceutica | Wikipedia: Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceutica) | 2026-09-20 | Wikipedia | publication | | | lede and History | CC BY-SA 4.0 | | | | |
| 39 | + | | wiki-loperamide | https://en.wikipedia.org/wiki/Loperamide | Wikipedia: Loperamide | 2026-09-20 | Wikipedia | publication | | | History | CC BY-SA 4.0 | | | | |
| 40 | + | | gleif-parent | https://api.gleif.org/api/v1/lei-records/549300OLOH8YMZM9O838/ultimate-parent | GLEIF Level 2: ultimate parent of Janssen Pharmaceutica (549300OLOH8YMZM9O838) | 2026-09-24 | GLEIF | registry | | 549300G0CFPGEF6X2043 | ultimate parent Johnson & Johnson; direct parent reported as non-public | CC0 | | | | |
| 40 | 41 | <!--/references--> | |
| 41 | 42 | ||
| 42 | 43 | ## About <!--about--> | |
| 43 | − | Janssen Pharmaceutica is the Belgian pharmaceutical company at Turnhoutseweg 30 in Beerse, wholly owned by Johnson & Johnson, and the house where loperamide was discovered and first sold as Imodium.[^wiki-janssen][^wiki-loperamide] The Crossroads Bank for Enterprises carries it as active enterprise 0403.834.160, a naamloze vennootschap whose Dutch name Janssen Pharmaceutica and start date of 23 October 1934 reach back to N.V. Produkten Richter, the medicines distributor Constant Janssen founded in Turnhout that year.[^kbo][^wiki-janssen] His son Paul Janssen set up his own research laboratory inside it in 1953, the firm was renamed after the family in 1956 and opened its Beerse research site in 1957, and Johnson & Johnson bought it in 1961.[^wiki-janssen] Paul Janssen's team synthesised loperamide hydrochloride there in 1969 and Janssen began promoting it as Imodium in 1973; that brand belongs to Kenvue today.[^wiki-loperamide] Since 1 January 2024 the register also records Johnson & Johnson Innovative Medicine, Johnson & Johnson, J&J and Janssen Research & Development as trade names of this entity, the group having retired the Janssen name from its medicines business.[^kbo][^wiki-janssen] GLEIF holds the company as 549300OLOH8YMZM9O838, registered at the Belgian register under the same number.[^gleif] | |
| 44 | − | ||
| 45 | − | What this stub does not settle: what part, if any, the Beerse entity plays in making or selling Imodium today, since the brand's owner Kenvue names only its own group companies, and which Johnson & Johnson company sits directly above it, the 1961 purchase being reported by an encyclopedia rather than by a shareholder filing. | |
| 44 | + | Janssen Pharmaceutica is the Belgian pharmaceutical company at Turnhoutseweg 30 in Beerse, wholly owned by Johnson & Johnson, and the house where loperamide was discovered and first sold as Imodium.[^wiki-janssen][^wiki-loperamide] The Crossroads Bank for Enterprises carries it as active enterprise 0403.834.160, a naamloze vennootschap whose Dutch name Janssen Pharmaceutica and start date of 23 October 1934 reach back to N.V. Produkten Richter, the medicines distributor Constant Janssen founded in Turnhout that year.[^kbo][^wiki-janssen] His son Paul Janssen set up his own research laboratory inside it in 1953, the firm was renamed after the family in 1956 and opened its Beerse research site in 1957, and Johnson & Johnson bought it on 25 October 1961; the name Janssen Pharmaceutica N.V. and the move of its seat from Turnhout to Beerse followed on 10 February 1964.[^wiki-janssen] GLEIF records Johnson & Johnson as the ultimate parent of the Beerse entity.[^gleif-parent] Paul Janssen's team synthesised loperamide hydrochloride there in 1969 and Janssen began promoting it as Imodium in 1973; that brand belongs to Kenvue today.[^wiki-loperamide] Since 1 January 2024 the register also records Johnson & Johnson Innovative Medicine, Johnson & Johnson, J&J and Janssen Research & Development as trade names of this entity, the group having retired the Janssen name from its medicines business.[^kbo][^wiki-janssen] GLEIF holds the company as 549300OLOH8YMZM9O838, registered at the Belgian register under the same number.[^gleif] | |
| 46 | 45 | <!--/about--> |
Source of v1
# Janssen Pharmaceutica <!--company-->
## Identity <!--identity-->
name: Janssen Pharmaceutica
summary: Belgian pharmaceutical company at Beerse, owned by Johnson & Johnson since 1961, where Paul Janssen's team discovered loperamide and launched it as Imodium.
legal_name: Janssen Pharmaceutica NV
registered_address: Turnhoutseweg 30, 2340 Beerse, Belgium
country: BE
register_ids: BE-KBO:0403834160, LEI:549300OLOH8YMZM9O838
founded: 1934-10-23
<!--/identity-->
## Relations <!--relations-->
| role | target | market | from | until | ended | status | source | note |
| -------- | ----------------------- | ------ | ---- | ----- | ----- | ------- | ------------- | ------------------------------------------------------------------------------------------------------------------ |
| owned_by | company/johnson-johnson | | 1961 | | | sourced | ^wiki-janssen | Johnson & Johnson bought the company in 1961 and holds it wholly; the Belgian register names no other shareholder. |
<!--/relations-->
## Establishments <!--establishments-->
| mark | kind | address | country | source | note |
| ---- | ------ | -------------------------------------- | ------- | ------ | ------------------------------------------------------- |
| | office | Turnhoutseweg 30, 2340 Beerse, Belgium | BE | ^kbo | Registered seat in the Crossroads Bank for Enterprises. |
<!--/establishments-->
## Aliases <!--aliases-->
| name | type | locale | from | until |
| ------------------------------------- | ------ | ------ | ---------- | ----- |
| Janssen Pharmaceutica NV | legal | | | |
| Johnson & Johnson Innovative Medicine | name | | 2024-01-01 | |
| Janssen | search | | | |
<!--/aliases-->
## References <!--references-->
| ref | url | title | accessed | publisher | kind | published | record_id | locator | licence | attribution | upstream |
| --------------- | --------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------- | ---------- | ------------------------------- | ----------- | --------- | -------------------- | ----------------------------------------------------------------- | ------------ | ----------- | -------- |
| kbo | https://kbopub.economie.fgov.be/kbopub/toonondernemingps.html?ondernemingsnummer=0403834160&lang=en | CBE Public Search: registered entity 0403.834.160, Janssen Pharmaceutica | 2026-09-20 | Crossroads Bank for Enterprises | registry | | 0403834160 | name, start date, registered seat, legal form, trade names | | | |
| gleif | https://api.gleif.org/api/v1/lei-records/549300OLOH8YMZM9O838 | GLEIF LEI record: JANSSEN PHARMACEUTICA (549300OLOH8YMZM9O838) | 2026-09-20 | GLEIF | registry | | 549300OLOH8YMZM9O838 | legal name, legal address, registeredAs 0403834160, entity status | CC0 | | |
| wiki-janssen | https://en.wikipedia.org/wiki/Janssen_Pharmaceutica | Wikipedia: Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceutica) | 2026-09-20 | Wikipedia | publication | | | lede and History | CC BY-SA 4.0 | | |
| wiki-loperamide | https://en.wikipedia.org/wiki/Loperamide | Wikipedia: Loperamide | 2026-09-20 | Wikipedia | publication | | | History | CC BY-SA 4.0 | | |
<!--/references-->
## About <!--about-->
Janssen Pharmaceutica is the Belgian pharmaceutical company at Turnhoutseweg 30 in Beerse, wholly owned by Johnson & Johnson, and the house where loperamide was discovered and first sold as Imodium.[^wiki-janssen][^wiki-loperamide] The Crossroads Bank for Enterprises carries it as active enterprise 0403.834.160, a naamloze vennootschap whose Dutch name Janssen Pharmaceutica and start date of 23 October 1934 reach back to N.V. Produkten Richter, the medicines distributor Constant Janssen founded in Turnhout that year.[^kbo][^wiki-janssen] His son Paul Janssen set up his own research laboratory inside it in 1953, the firm was renamed after the family in 1956 and opened its Beerse research site in 1957, and Johnson & Johnson bought it in 1961.[^wiki-janssen] Paul Janssen's team synthesised loperamide hydrochloride there in 1969 and Janssen began promoting it as Imodium in 1973; that brand belongs to Kenvue today.[^wiki-loperamide] Since 1 January 2024 the register also records Johnson & Johnson Innovative Medicine, Johnson & Johnson, J&J and Janssen Research & Development as trade names of this entity, the group having retired the Janssen name from its medicines business.[^kbo][^wiki-janssen] GLEIF holds the company as 549300OLOH8YMZM9O838, registered at the Belgian register under the same number.[^gleif]
What this stub does not settle: what part, if any, the Beerse entity plays in making or selling Imodium today, since the brand's owner Kenvue names only its own group companies, and which Johnson & Johnson company sits directly above it, the 1961 purchase being reported by an encyclopedia rather than by a shareholder filing.
<!--/about-->